Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
94 studies found for:    weill | "RNA Virus Infections"
Show Display Options
Rank Status Study
1 Terminated Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I
Condition: Hepatitis C
Interventions: Biological: Interleukin 2;   Drug: Ribavirin;   Biological: Pegylated Interferon Alpha;   Biological: Inteleukin-2;   Drug: Ribavirin + Pegylated interferon-alpha
2 Terminated Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
Conditions: Anemia;   Neutropenia;   Hepatitis C Virus;   HIV Infections
Intervention: Drug: erythropoietin, GCSF
3 Unknown  The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hepatitis C;   Liver Cirrhosis
Intervention: Drug: Rifaximin (drug)
4 Completed
Has Results
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Conditions: HIV-Associated Lipodystrophy Syndrome;   Insulin Resistance;   HIV Infections;   Metabolic Syndrome X;   Body Weight Changes
Interventions: Drug: Rosiglitazone;   Drug: Recombinant human growth hormone + rosiglitazone
5 Terminated Armodafinil for Patients Starting Hepatitis C Virus Treatment
Condition: Hepatitis C
Interventions: Drug: Armodafinil;   Drug: Placebo Comparator
6 Enrolling by invitation Hepatitis C Treatment in Underserved Populations
Conditions: Chronic Hepatitis C;   Illicit Drug Use
Intervention: Other: Collaborative, multidisciplinary, integrated care
7 Completed The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: Shang Ring circumcision
8 Completed
Has Results
Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV)
Condition: Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin
9 Completed Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects
Condition: Chronic Hepatitis C
Intervention: Drug: Ribavirin, PEG-Intron
10 Completed Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
11 Completed
Has Results
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Nitazoxanide;   Drug: Placebo;   Biological: Peginterferon alfa-2a;   Drug: Ribavirin
12 Completed Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV
Condition: HIV Infections
Interventions: Biological: ALVAC HIV vaccine (vCP1452);   Drug: Interleukin-2
13 Completed
Has Results
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate
14 Completed
Has Results
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: Nitazoxanide;   Drug: Placebo;   Biological: Peginterferon alfa-2a;   Drug: Ribavirin
15 Recruiting Integrase and Maraviroc Intensification for Neurocognitive Dysfunction (InMIND)
Condition: HIV Infections
Interventions: Drug: Placebo for maraviroc (MVC);   Drug: Placebo for dolutegravir (DTG);   Drug: Dolutegravir (DTG);   Drug: Maraviroc (MVC)
16 Recruiting Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Condition: HIV Infections
Intervention: Drug: Ruxolitinib
17 Recruiting Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Conditions: HIV Infections;   Cardiovascular Diseases
Interventions: Drug: Pitavastatin;   Drug: Placebo
18 Recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT);   Drug: Dasabuvir (DSV);   Drug: Ribavirin (RBV)
19 Completed
Has Results
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Pegylated-Interferon Alfa 2b (PEG-IFN);   Drug: Ribavirin (RBV);   Drug: Boceprevir (BOC)
20 Completed Evaluating the Effectiveness of the Quadrivalent Human Papillomavirus (HPV) Vaccine at Preventing Anal HPV Infection in HIV-Infected Men and Women
Condition: HIV Infections
Interventions: Biological: Quadrivalent HPV Vaccine;   Biological: Placebo Vaccine for Male Participants Only;   Biological: Placebo Vaccine for Female Participants Only

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years